title: Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
abstract: Small cell carcinoma of prostate (PSCC) is an uncommon and aggressive type of prostate malignancy with limited data on the use of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in the clinical management of this rare entity. In this report, clinical and imaging findings of a patient with PSCC are presented. We aimed to discuss the role of PET/CT in the evaluation of PSCC in combination with histopathological characteristics of tumor and emphasize the importance of PET/CT in the clinical management of PSCC.
authors.affiliation: Department of Nuclear Medicine, Ankara Oncology Research and Training Hospital, Ankara, Turkey. ilginsahiner@yahoo.com
authors.forename: I
authors.initials: I
authors.lastname: Sahiner
authors.forename: B E
authors.initials: BE
authors.lastname: Akkas
authors.forename: G
authors.initials: G
authors.lastname: Ucmak Vural
mesh_terms: D000368:Aged; D018288:Carcinoma, Small Cell / Q000175:diagnosis*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18